MediSapiens finds company in the US
Finnish company MediSapiens has partnered with Mars Petcare to drive advancements in precision healthcare for companion animals.
MediSapiens has for years contributed to the development and maintenance of an integrated sample management, bioinformatics data analysis and result reporting system for MyDogDNA, the leading genetic testing service for dogs on the planet.
The new partnership, it views, will enable it to consolidate its commitment to accelerate the discovery of genetic markers and the promotion of health for companion animals.
“We see tremendous opportunities in bringing the latest technologies for precision healthcare and discovery to Mars Petcare. Their dedication to targeted, preventative and individualised care is admirable, as well as their reach within the animal community,” says Kuisma.
Headquartered in the US, Mars Petcare is the world’s leading pet nutrition and healthcare business with a portfolio of brands including Pedigree, Whiskas, Royal Canin and Banfield.